Clinical Trial Update: Pilot Study of a Raltegravir Based NRTI Sparing Regimen [NA]

View source ↗

Summary

This update reports the completion and posted results of a pilot study evaluating a raltegravir-based, NRTI-sparing regimen in people with HIV/AIDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immune Deficiency Syndrome
• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Yale University | Conditions: Acquired Immune Deficiency Syndrome, AIDS | NA | Status: COMPLETED | Results posted: 2016-02-04